+1 347 708 0418
This report studies the Heart Failure Drugs market, covering market size for segment by type (Injection, Capsule, etc.), by application (Hospital Pharmacy, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, Pfizer, AstraZeneca, Hikma, Teva, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Heart Failure Drugs from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Heart Failure Drugs market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Heart Failure Drugs including:
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Sanofi
GSK
Bristol-Myers Squibb
Bausch Health
Johnson & Johnson
Bayer
Boehringer Inhelheim
Exelixis
Lunan Pharmaceutical
Sinepharm
CRC
Hai Ni Pharmaceutical
Langtian
NCPC
Hayao
Xinhua Group
Xudong Haipu Pharmaceutical
Market split by Type, can be divided into:
Injection
Capsule
Tablets
Market split by Application, can be divided into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Heart Failure Drugs Market Overview
1.1 Heart Failure Drugs Definition
1.2 Global Heart Failure Drugs Market Size Status and Outlook (2016-2030)
1.3 Global Heart Failure Drugs Market Size Comparison by Region (2016-2030)
1.4 Global Heart Failure Drugs Market Size Comparison by Type (2016-2030)
1.5 Global Heart Failure Drugs Market Size Comparison by Application (2016-2030)
1.6 Global Heart Failure Drugs Market Size Comparison by Sales Channel (2016-2030)
1.7 Heart Failure Drugs Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Heart Failure Drugs Market Segment Analysis by Player
2.1 Global Heart Failure Drugs Sales and Market Share by Player (2019-2021)
2.2 Global Heart Failure Drugs Revenue and Market Share by Player (2019-2021)
2.3 Global Heart Failure Drugs Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Heart Failure Drugs Market Segment Analysis by Type
3.1 Global Heart Failure Drugs Market by Type
3.1.1 Injection
3.1.2 Capsule
3.1.3 Tablets
3.2 Global Heart Failure Drugs Sales and Market Share by Type (2016-2021)
3.3 Global Heart Failure Drugs Revenue and Market Share by Type (2016-2021)
3.4 Global Heart Failure Drugs Average Price by Type (2016-2021)
3.5 Leading Players of Heart Failure Drugs by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Heart Failure Drugs Market Segment Analysis by Application
4.1 Global Heart Failure Drugs Market by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Heart Failure Drugs Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Heart Failure Drugs by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Heart Failure Drugs Market Segment Analysis by Sales Channel
5.1 Global Heart Failure Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Heart Failure Drugs Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Heart Failure Drugs by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Heart Failure Drugs Market Segment Analysis by Region
6.1 Global Heart Failure Drugs Market Size and CAGR by Region (2016-2030)
6.2 Global Heart Failure Drugs Sales and Market Share by Region (2016-2021)
6.3 Global Heart Failure Drugs Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Heart Failure Drugs Market Share by Type
6.4.3 North America Heart Failure Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Heart Failure Drugs Market Share by Type
6.5.3 Europe Heart Failure Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Heart Failure Drugs Market Share by Type
6.6.3 Asia-Pacific Heart Failure Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Heart Failure Drugs Market Share by Type
6.7.3 South America Heart Failure Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Heart Failure Drugs Market Share by Type
6.8.3 Middle East & Africa Heart Failure Drugs Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Heart Failure Drugs Players
7.1 Novartis
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Pfizer
7.3 AstraZeneca
7.4 Hikma
7.5 Teva
7.6 Cipla
7.7 Merck & Co.
7.8 Amgen
7.9 Roche
7.10 Sun Pharma
7.11 Mylan
7.12 Sanofi
7.13 GSK
7.14 Bristol-Myers Squibb
7.15 Bausch Health
7.16 Johnson & Johnson
7.17 Bayer
7.18 Boehringer Inhelheim
7.19 Exelixis
7.20 Lunan Pharmaceutical
7.21 Sinepharm
7.22 CRC
7.23 Hai Ni Pharmaceutical
7.24 Langtian
7.25 NCPC
7.26 Hayao
7.27 Xinhua Group
7.28 Xudong Haipu Pharmaceutical
Chapter 8 Upstream and Downstream Analysis of Heart Failure Drugs
8.1 Industrial Chain of Heart Failure Drugs
8.2 Upstream of Heart Failure Drugs
8.3 Downstream of Heart Failure Drugs
Chapter 9 Development Trend of Heart Failure Drugs (2022-2030)
9.1 Global Heart Failure Drugs Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Heart Failure Drugs Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Heart Failure Drugs Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Heart Failure Drugs Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Heart Failure Drugs Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Heart Failure Drugs Example
Figure Global Heart Failure Drugs Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Heart Failure Drugs Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Heart Failure Drugs Sales by Player (2019-2021)
Table Global Heart Failure Drugs Sales Market Share by Player (2019-2021)
Figure Global Heart Failure Drugs Sales Market Share by Player in 2021
Table Global Heart Failure Drugs Revenue (Million $) by Player (2019-2021)
Table Global Heart Failure Drugs Revenue Market Share by Player (2019-2021)
Figure Global Heart Failure Drugs Revenue Market Share by Player in 2021
Table Global Heart Failure Drugs Average Price by Player (2019-2021)
Figure Global Heart Failure Drugs Average Price by Player in 2021
Figure Global Heart Failure Drugs Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Heart Failure Drugs Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Injection
Figure Global Injection Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Capsule
Figure Global Capsule Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Tablets
Figure Global Tablets Revenue (Million $) and Growth Rate (2016-2021)
Table Global Heart Failure Drugs Sales by Type (2016-2021)
Table Global Heart Failure Drugs Sales Market Share by Type (2016-2021)
Figure Global Heart Failure Drugs Sales Market Share by Type in 2021
Table Global Heart Failure Drugs Revenue (Million $) by Type (2016-2021)
Table Global Heart Failure Drugs Revenue Market Share by Type (2016-2021)
Figure Global Heart Failure Drugs Revenue Market Share by Type in 2021
Table Global Heart Failure Drugs Average Price by Type (2016-2021)
Figure Global Heart Failure Drugs Average Price by Type in 2021
Table Leading Players of Heart Failure Drugs by Type in 2021
Figure Example of Hospital Pharmacy
Figure Global Heart Failure Drugs for Hospital Pharmacy Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Retail Pharmacy
Figure Global Heart Failure Drugs for Retail Pharmacy Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Online Pharmacy
Figure Global Heart Failure Drugs for Online Pharmacy Revenue (Million $) and Growth Rate (2016-2021)
Table Global Heart Failure Drugs Sales by Application (2016-2021)
Table Global Heart Failure Drugs Sales Market Share by Application (2016-2021)
Figure Global Heart Failure Drugs Sales Market Share by Application in 2021
Table Leading Consumers of Heart Failure Drugs by Application in 2021
Figure Example of Direct Channel
Figure Global Heart Failure Drugs for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Heart Failure Drugs for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Heart Failure Drugs Revenue by Sales Channel (2016-2021)
Table Global Heart Failure Drugs Revenue Market Share by Sales Channel (2016-2021)
Figure Global Heart Failure Drugs Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Heart Failure Drugs by Sales Channel in 2021
Table Global Heart Failure Drugs Market Size and CAGR by Region (2016-2030)
Table Global Heart Failure Drugs Sales by Region (2016-2021)
Table Global Heart Failure Drugs Sales Market Share by Region (2016-2021)
Figure Global Heart Failure Drugs Sales Market Share by Region in 2021
Table Global Heart Failure Drugs Revenue (Million $) by Region (2016-2021)
Table Global Heart Failure Drugs Revenue Market Share by Region (2016-2021)
Figure Global Heart Failure Drugs Revenue Market Share by Region in 2021
Table North America Heart Failure Drugs Sales by Country (2016-2021)
Figure North America Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table North America Heart Failure Drugs Revenue by Country (2016-2021)
Figure North America Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Figure North America Heart Failure Drugs Market Share by Type in 2021
Figure North America Heart Failure Drugs Market Share by Application in 2021
Figure United States Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure United States Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Canada Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Mexico Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Heart Failure Drugs Sales by Country (2016-2021)
Figure Europe Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table Europe Heart Failure Drugs Revenue by Country (2016-2021)
Figure Europe Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Figure Europe Heart Failure Drugs Market Share by Type in 2021
Figure Europe Heart Failure Drugs Market Share by Application in 2021
Figure Germany Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Germany Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure UK Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure France Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure France Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Italy Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Russia Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Spain Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Heart Failure Drugs Sales by Country (2016-2021)
Figure Asia-Pacific Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table Asia-Pacific Heart Failure Drugs Revenue by Country (2016-2021)
Figure Asia-Pacific Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Heart Failure Drugs Market Share by Type in 2021
Figure Asia-Pacific Heart Failure Drugs Market Share by Application in 2021
Figure China Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure China Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Japan Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Korea Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure India Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure India Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Southeast Asia Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Australia Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table South America Heart Failure Drugs Sales by Country (2016-2021)
Figure South America Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table South America Heart Failure Drugs Revenue by Country (2016-2021)
Figure South America Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Figure South America Heart Failure Drugs Market Share by Type in 2021
Figure South America Heart Failure Drugs Market Share by Application in 2021
Figure Brazil Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Brazil Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Argentina Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Colombia Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Heart Failure Drugs Sales by Country (2016-2021)
Figure Middle East & Africa Heart Failure Drugs Sales Market Share by Country (2016-2021)
Table Middle East & Africa Heart Failure Drugs Revenue by Country (2016-2021)
Figure Middle East & Africa Heart Failure Drugs Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Heart Failure Drugs Market Share by Type in 2021
Figure Middle East & Africa Heart Failure Drugs Market Share by Application in 2021
Figure UAE Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure UAE Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Heart Failure Drugs Sales and Growth Rate (2016-2021)
Figure South Africa Heart Failure Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Novartis
Table Heart Failure Drugs Introduction of Novartis
Table Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share of Novartis (2019-2021)
Table Industrial Chain of Heart Failure Drugs
Table Manufacturing Cost Structure of Heart Failure Drugs
Table General Manufacturing Process of Heart Failure Drugs
Table Leading Distributors/Dealers of Heart Failure Drugs
Table Leading Consumers of Heart Failure Drugs
Figure Global Heart Failure Drugs Sales and Growth Rate Forecast (2022-2030)
Figure Global Heart Failure Drugs Revenue and Growth Rate Forecast (2022-2030)
Table Global Heart Failure Drugs Market Size and CAGR Forecast by Region (2022-2030)
Table Global Heart Failure Drugs Market Size and CAGR Forecast by Type (2022-2030)
Table Global Heart Failure Drugs Market Size and CAGR Forecast by Application (2022-2030)
Table Global Heart Failure Drugs Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
